Faro Raises $37.3M for Clinical Trial AI
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Faro raised a $37.3M Series B round co-led by Merck Global Health Innovation Fund and S32 to develop AI tools that speed up clinical trials.
- Faro builds data models and AI tools aimed at compressing clinical trial timelines, a notoriously expensive and slow phase of drug development.
Why it matters: A $37.3M round co-led by Merck Global Health Innovation Fund gives Faro both fresh capital and a pharma-aligned backer for its clinical-trial AI platform, where the source says the company's explicit mission is cutting trial timelines — one of the costliest bottlenecks in drug development.
Ask SkimNews
